Details for New Drug Application (NDA): 009149
✉ Email this page to a colleague
NDA 009149 describes THORAZINE, which is a drug marketed by Glaxosmithkline and is included in two NDAs. Additional details are available on the THORAZINE profile page.
The generic ingredient in THORAZINE is chlorpromazine. There are twenty-four drug master file entries for this compound. Additional details are available on the chlorpromazine profile page.
The generic ingredient in THORAZINE is chlorpromazine. There are twenty-four drug master file entries for this compound. Additional details are available on the chlorpromazine profile page.
Summary for 009149
| Tradename: | THORAZINE |
| Applicant: | Glaxosmithkline |
| Ingredient: | chlorpromazine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 009149
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 007
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 011
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
